A Study Testing the Effect and Safety of Casopitant (GW679769) While Taking Warfarin in Healthy Human Volunteers

Completed · Phase 1

Conditions studied: Nausea and Vomiting, Chemotherapy-Induced

In brief

GW679769 may affect liver enzymes that metabolize warfarin. This study is designed to test the extent of the GW679769 affect on Warfarin levels in humans.

Key facts

Study ID
NCT00404274
Run by
GlaxoSmithKline
People needed
97
Starts
2006-11-01
Expected to finish
2007-03-18
Last updated by the study team
2017-08-09

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.